Novel treatment for obstructive sleep apnea

Summary

Novel treatment for obstructive sleep apnea

Supervisor(s)

Professor Peter Cistulli

Research Location

Camperdown - Woolcock Institute of Medical Research

Program Type

Masters/PHD

Synopsis

Obstructive sleep apnoea (OSA) is a serious public health problem, affecting approximately 2% of women and 4% of men in the middle-aged workforce. Continuous positive airway pressure (CPAP) applied to the upper airway via a nose mask during sleep is the accepted treatment of choice. Whilst it is an extremely effective treatment, its cumbersome nature makes tolerance and compliance less than optimal, attenuating the benefits achievable in the clinical setting. Oral appliances are an emerging treatment alternative to CPAP. Our group is at the forefront of research into the mechanisms of action and clinical outcomes of this treatment modality. A range of research projects are in progress, including upper airway imaging studies, physiological research, and clinical trials.

Want to find out more?

Contact us to find out what’s involved in applying for a PhD.

Contact Research Expert to find out more about participating in this opportunity.

Browse for other opportunities within the Camperdown - Woolcock Institute of Medical Research .

Keywords

Obstructive Sleep Apnea, Snoring, Upper airway, Continuous Positive Airway Pressure, Oral Appliance treatment, CPAP, Cardiovascular & respiratory diseases, Counselling & patient support, Neuroscience & psychology, Respiration

Opportunity ID

The opportunity ID for this research opportunity is: 210

Other opportunities with Professor Peter Cistulli